Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models.
Publication
, Journal Article
Lyman, GH; Kuderer, NM
Published in: Cancer Invest
July 2024
Duke Scholars
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
July 2024
Volume
42
Issue
6
Start / End Page
447 / 451
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Biomedical Research
- Artificial Intelligence
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Kuderer, N. M. (2024). Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models. Cancer Invest, 42(6), 447–451. https://doi.org/10.1080/07357907.2024.2354991
Lyman, Gary H., and Nicole M. Kuderer. “Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models.” Cancer Invest 42, no. 6 (July 2024): 447–51. https://doi.org/10.1080/07357907.2024.2354991.
Lyman GH, Kuderer NM. Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models. Cancer Invest. 2024 Jul;42(6):447–51.
Lyman, Gary H., and Nicole M. Kuderer. “Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models.” Cancer Invest, vol. 42, no. 6, July 2024, pp. 447–51. Pubmed, doi:10.1080/07357907.2024.2354991.
Lyman GH, Kuderer NM. Artificial Intelligence in Cancer Clinical Research: II. Development and Validation of Clinical Prediction Models. Cancer Invest. 2024 Jul;42(6):447–451.
Published In
Cancer Invest
DOI
EISSN
1532-4192
Publication Date
July 2024
Volume
42
Issue
6
Start / End Page
447 / 451
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Biomedical Research
- Artificial Intelligence
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis